A controlled trial with vasopressin analogue (DGAVP) on cognitive recovery immediately after head trauma
- 1 January 1993
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 43 (1_part_1) , 103
- https://doi.org/10.1212/wnl.43.1_part_1.103
Abstract
Recent evidence suggests that the vasopressin analogue desglycinamide-arginine8-vasopressin (DGAVP) might specifically benefit mild brain trauma patients. We investigated the effect of intranasal DGAVP treatment in 32 patients who had sustained a mild head injury for 3 months in a double-blind, placebo-controlled, matched-pairs study. DGAVP did not have a positive effect on cognitive recovery in this group of mildly affected patients.Keywords
This publication has 0 references indexed in Scilit: